A Study of Genetic Variation Influencing Pain and Response to Opioid Medications in Patients With Chronic Pain

The investigators will be collecting saliva DNA samples from chronic back pain patients. The investigators hope to find candidate genes associated with response to opioid medication by correlating molecular genetics data with pain measurement and opioid responsiveness data including opioid hyperalgesia and opioid analgesic tolerance.

Stanford is now accepting new patients for this trial. Please contact Dan Hoang at 6508874677 for more information.

Investigator(s):

Phase: N/A

Eligibility

Ages Eligible For Study:

18 Years - 71 Years

Inclusion Criteria

1. Adult patient, aged 18-71 2. Recipient of chronic opioid therapy 3. Patient is able to produce a saliva sample 4. If a past study participant, patient will have agreed to be contacted for future studies.

External Links

Contact information

Primary Contact:

Dan Hoang 6508874677

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: